RE:RE:RE:RE:RE:RE:Beam Therapeutics Phase 1 CAR-T study placed on hold by FDAManipulation is one thing but... lack of interest by the market is the responsability of management. It's a big miss by the board. Recent events like insiders transactions and the addition of Mr. Parsons are positives. We need more it seems, to get institutions interest.